US Broker Ratings

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 64.50% Potential Upside for Investors

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, specifically within the medical devices industry, is showcasing intriguing opportunities for investors. Headquartered in Marlborough, Massachusetts, Boston Scientific..

Thermo Fisher Scientific Inc (TMO): Analyst Consensus Points to 11% Upside Potential

Thermo Fisher Scientific Inc (NYSE: TMO), a heavyweight in the healthcare sector with a robust market capitalization of $197.88 billion, continues to capture investor interest. Known for its extensive portfolio..

AbbVie Inc. (ABBV): Investor Outlook Highlights Robust Revenue Growth and Dividend Appeal

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor attention with its impressive market capitalization of $449.63 billion. This pharmaceutical giant, headquartered in North Chicago,..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Navigating a Stable Path in Biotechnology

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company focused on developing treatments for rare diseases, is drawing investor attention with its consistent market positioning and intriguing financial metrics. With a..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring an 87% Upside Potential in the Biotech Sector

Vaxcyte, Inc. (NASDAQ: PCVX) is making waves in the biotechnology sector, attracting investor attention with its promising vaccine pipeline and notable upside potential. With an impressive market capitalization of $8.41..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Investors Eye Potential 18.29% Upside in CNS Drug Innovator

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has captured the attention of investors with its promising pipeline of novel therapies targeting central nervous system (CNS) disorders, a sector that continues to see..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth Potential with a 4.61% Upside

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a current market capitalization of $3.18 billion. As..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech Powerhouse with 27% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) has emerged as a formidable contender in the biotechnology sector, with its innovative approach to muscle activators and inhibitors. With a market capitalization of $11.52 billion,..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Unpacking a 26.46% Potential Upside

Madrigal Pharmaceuticals, Inc. (MDGL) is making waves in the biotechnology sector, particularly within the niche of metabolic dysfunction-associated steatohepatitis (MASH), a condition with significant unmet medical needs. Based in West..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a Potential 49.45% Upside for Healthcare Investors

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the global healthcare sector, is drawing investor attention with a compelling potential upside of 49.45%. Headquartered in Barcelona, Spain, Grifols specializes in..

Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX) stands as a formidable entity in the healthcare sector, specializing in the development and supply of single-use medical devices. With a market capitalization of $6.01 billion,..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Is the Current Valuation Justified Amidst Strong Revenue Growth?

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, specializes in providing vital clinical research-based services for drug and medical device development across the globe. With a..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 21.93% Upside Potential Beckons Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out in the healthcare sector, specifically in the medical instruments and supplies industry, with a robust market capitalization of $4.38 billion. This U.S.-based..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 28.91% Upside Potential in Biotechnology

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its focus on tackling rare neuroendocrine diseases. Based in Boston, Massachusetts, this commercial-stage biopharmaceutical company has garnered..

Waystar Holding Corp. (WAY) Stock Analysis: Unveiling a 49.64% Potential Upside

For investors eyeing the healthcare sector, Waystar Holding Corp. (WAY) presents an intriguing opportunity. This Lehi, Utah-based company specializes in health information services, offering a robust cloud-based software solution that..

Oscar Health, Inc. (OSCR) Stock Analysis: Evaluating Growth Potential Amidst a Robust 52.60% Revenue Surge

Oscar Health, Inc. (NYSE: OSCR) has emerged as a notable player in the healthcare technology sector, captivating investor interest due to its impressive revenue growth and innovative approach to healthcare..

Legend Biotech Corporation (LEGN) Stock Analysis: A Promising 111% Potential Upside in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) is gaining attention within the healthcare sector, particularly in the biotechnology industry, where it is making impressive strides in cell therapy for oncology. With a..

Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 36.61% Potential Upside in a Competitive Market

Prestige Consumer Healthcare Inc. (NYSE: PBH), a formidable player in the healthcare sector, has captured investor attention with its diverse portfolio of over-the-counter health and personal care products. Headquartered in..

Telix Pharmaceuticals Limited (TLX): Analyst Consensus and Growth Potential with an 87% Upside

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biotechnology sector, is capturing investor attention with its impressive growth trajectory and significant upside potential. Headquartered in North Melbourne, Australia,..

Tempus AI, Inc. (TEM) Stock Report: Navigating Growth Amid a 13.45% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM) is fast becoming a focal point for investors keen on the intersection of healthcare and technology. With a market capitalization of $10.46 billion, the company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds